CVA Family Office’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | -$487 | – | 1310 |
|
|
2025
Q1 | $487 | Sell |
2
-67
| -97% | -$16.3K | ﹤0.01% | 1282 |
|
|
2024
Q4 | $22.7K | Hold |
69
| – | – | ﹤0.01% | 654 |
|
|
2024
Q3 | $23.1K | Buy |
69
+2
| +3% | +$669 | ﹤0.01% | 631 |
|
|
2024
Q2 | $18.3K | Buy |
+67
| New | +$18.3K | ﹤0.01% | 656 |
|
|
2022
Q3 | – | Sell |
-15
| Closed | -$7K | – | 876 |
|
|
2022
Q2 | $7K | Buy |
15
+5
| +50% | +$2.33K | ﹤0.01% | 694 |
|
|
2022
Q1 | $6K | Buy |
10
+5
| +100% | +$3K | ﹤0.01% | 739 |
|
|
2021
Q4 | $4K | Buy |
+5
| New | +$4K | ﹤0.01% | 765 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | -$3K | – | 421 |
|
|
2021
Q2 | $3K | Sell |
5
-15
| -75% | -$9K | ﹤0.01% | 820 |
|
|
2021
Q1 | $11K | Buy |
+20
| New | +$11K | ﹤0.01% | 505 |
|